NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · IEX Real-Time Price · USD
0.869
-0.027 (-2.99%)
At close: Jul 2, 2024, 4:00 PM
0.877
+0.008 (0.89%)
After-hours: Jul 2, 2024, 6:59 PM EDT

NMTC Income Statement

Millions USD. Fiscal year is Oct - Sep.
Year
20232022202120202019 2018
Revenue
3.412.120.241.930
Upgrade
Revenue Growth (YoY)
60.73%772.60%-87.39%--
Upgrade
Cost of Revenue
1.50.240.2800
Upgrade
Gross Profit
1.911.88-0.031.930
Upgrade
Selling, General & Admin
6.936.986.264.754.28
Upgrade
Research & Development
6.944.933.932.081.53
Upgrade
Operating Expenses
13.8711.9110.196.835.81
Upgrade
Operating Income
-11.96-10.03-10.22-4.9-5.81
Upgrade
Interest Expense / Income
0007.520.28
Upgrade
Other Expense / Income
-0.1-0.03-0.271.210.68
Upgrade
Pretax Income
-11.86-10-9.95-13.64-6.78
Upgrade
Net Income
-11.86-10-9.95-13.64-6.78
Upgrade
Shares Outstanding (Basic)
18161154
Upgrade
Shares Outstanding (Diluted)
18161154
Upgrade
Shares Change
13.27%49.56%97.52%37.01%79.39%
Upgrade
EPS (Basic)
-0.65-0.63-0.93-2.52-1.71
Upgrade
EPS (Diluted)
-0.65-0.63-0.93-2.52-1.71
Upgrade
Free Cash Flow
-13.26-7.79-8.67-3.55-5.45
Upgrade
Free Cash Flow Per Share
-0.73-0.49-0.81-0.66-1.38
Upgrade
Gross Margin
56.10%88.59%-13.56%100.00%-
Upgrade
Operating Margin
-350.84%-473.14%-4205.75%-254.46%-
Upgrade
Profit Margin
-348.03%-471.67%-4094.60%-708.00%-
Upgrade
Free Cash Flow Margin
-389.23%-367.67%-3568.48%-184.15%-
Upgrade
EBITDA
-11.55-9.77-9.8-6.05-6.47
Upgrade
EBITDA Margin
-338.96%-461.00%-4032.79%-313.77%-
Upgrade
Depreciation & Amortization
0.310.230.150.070.03
Upgrade
EBIT
-11.86-10-9.95-6.12-6.5
Upgrade
EBIT Margin
-348.03%-471.67%-4093.35%-317.43%-
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).